Abstract

BackgroundSystemic lupus erythematosus (SLE) is a remarkably heterogeneous autoimmune disease. Despite tremendous efforts, our knowledge of serum protein patterns in severe SLE phenotypes is still limited. We investigated the serum protein pattern of SLE, with special emphasis on irreversible organ damage and active lupus nephritis (LN) as assessed by renal Systemic Lupus Erythematosus Disease Activity Index.MethodsWe used proximity extension immunoassay (PEA, Proseek Multiplex, Olink) to assess the serum levels of ninety-two inflammation-related proteins in Czech patients with SLE (n = 75) and age-matched healthy control subjects (n = 23). Subgroup analysis was carried out on the basis of organ damage (with/without, 42/33) and biopsy-proven LN (with/without, 27/48; active LN, n = 13; inactive LN, n = 14).ResultsOf thirty deregulated proteins between SLE and the healthy controls (Pcorr < 0.05), the top upregulated proteins in SLE were sirtuin 2, interleukin 18 (IL18), and caspase 8 (Pcorr < 0.0006). Of these, sirtuin 2 and caspase 8 had not yet been reported with SLE. Elevated levels of IL8, CCL2/MCP1, CCL11, and MMP10 (Pcorr < 0.05) were detected in patients with organ damage for which the serum levels of CCL11 and MMP10 were particularly informative in organ damage prediction. Comparing patients based on LN, elevated levels of CSF1, sIL15RA, sCD40, sCX3CL1, caspase 8, sIL18R1, bNGF, and GDNF (Pcorr < 0.05) were detected in active LN. Except GDNF, all LN-associated markers showed usefulness in prediction of active renal disease.ConclusionsThis highly sensitive PEA analysis identified the serum pattern of SLE, organ damage, and active LN, with many novel candidate proteins detected. Their exact role and suitability as biomarkers in SLE deserve further investigation.

Highlights

  • Systemic lupus erythematosus (SLE) is a remarkably heterogeneous autoimmune disease

  • Protein pattern of SLE In order to assess the serum protein fingerprint associated with SLE, we compared the serum protein levels obtained by proximity extension immunoassay (PEA) immunoassay in the SLE patients and healthy controls

  • The analysis revealed elevation of six IFN-regulated cytokines (IL6, C-C motif chemokine ligand 2 (CCL2)/MCP1, C-C motif chemokine ligand 3 (CCL3)/ MIP-1α, sCD40, C-X-C motif chemokine ligand 11 (CXCL11), and C-C motif chemokine ligand 19 (CCL19); Pcorr ≤ 0.01) in SLE and three (CCL8/MCP2, C-X-C motif chemokine ligand 9 (CXCL9), and C-X-C motif chemokine ligand 10 (CXCL10)) did not reach significance (Pcorr > 0.05)

Read more

Summary

Introduction

Systemic lupus erythematosus (SLE) is a remarkably heterogeneous autoimmune disease. Our knowledge of serum protein patterns in severe SLE phenotypes is still limited. We investigated the serum protein pattern of SLE, with special emphasis on irreversible organ damage and active lupus nephritis (LN) as assessed by renal Systemic Lupus Erythematosus Disease Activity Index. Systemic lupus erythematosus (SLE) is a serious, complex, multi-system autoimmune rheumatic disease with significant variability in the phenotypes and severity of. Organ damage is a primary outcome in SLE, which is accrued during the disease course, and by therapy itself [1]. The Systemic Lupus International Collaborating Clinics/American College of Rheumatology SLICC/ACR Damage Index (SDI), divided into 38 items grouped in 12 organ systems, is a valid measure of irreversible organ damage in SLE [1]. Prevention of irreversible damage is a major goal in the management of SLE patients and identification of the key molecules involved in the pathogenesis of organ damage is needed

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call